0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Nicotinamide Phosphoribosyltransferase Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-18R9482
Home | Market Reports | Health| Nutrition| Vitamins & Supplements
Global Nicotinamide Phosphoribosyltransferase Market Insights and Forecast to 2028
BUY CHAPTERS

Global Nicotinamide Phosphoribosyltransferase Market Research Report 2025

Code: QYRE-Auto-18R9482
Report
September 2025
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Nicotinamide Phosphoribosyltransferase Market

The global market for Nicotinamide Phosphoribosyltransferase was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Nicotinamide Phosphoribosyltransferase is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Nicotinamide Phosphoribosyltransferase is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Nicotinamide Phosphoribosyltransferase include Genentech, Inc., Angelini Group, Calico LLC, FORMA Therapeutics, Inc., OncoTartis, Inc., Karyopharm Therapeutics, Inc., Aurigene Discovery Technologies Limited, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Nicotinamide Phosphoribosyltransferase, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nicotinamide Phosphoribosyltransferase.
The Nicotinamide Phosphoribosyltransferase market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nicotinamide Phosphoribosyltransferase market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nicotinamide Phosphoribosyltransferase manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Nicotinamide Phosphoribosyltransferase Market Report

Report Metric Details
Report Name Nicotinamide Phosphoribosyltransferase Market
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Genentech, Inc., Angelini Group, Calico LLC, FORMA Therapeutics, Inc., OncoTartis, Inc., Karyopharm Therapeutics, Inc., Aurigene Discovery Technologies Limited
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Nicotinamide Phosphoribosyltransferase manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Nicotinamide Phosphoribosyltransferase in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Nicotinamide Phosphoribosyltransferase Market report?

Ans: The main players in the Nicotinamide Phosphoribosyltransferase Market are Genentech, Inc., Angelini Group, Calico LLC, FORMA Therapeutics, Inc., OncoTartis, Inc., Karyopharm Therapeutics, Inc., Aurigene Discovery Technologies Limited

What are the Application segmentation covered in the Nicotinamide Phosphoribosyltransferase Market report?

Ans: The Applications covered in the Nicotinamide Phosphoribosyltransferase Market report are Parkinson's Disease, Acute Lung Injury, Breast Cancer, Others

What are the Type segmentation covered in the Nicotinamide Phosphoribosyltransferase Market report?

Ans: The Types covered in the Nicotinamide Phosphoribosyltransferase Market report are Hormone, Lipids, Small Molecule Compounds, Others

Recommended Reports

Nicotinamide Products

Active Pharmaceutical Ingredients

Cosmetics and Supplements

1 Nicotinamide Phosphoribosyltransferase Market Overview
1.1 Product Definition
1.2 Nicotinamide Phosphoribosyltransferase by Type
1.2.1 Global Nicotinamide Phosphoribosyltransferase Market Value Comparison by Type (2024 VS 2031)
1.2.2 Hormone
1.2.3 Lipids
1.2.4 Small Molecule Compounds
1.2.5 Others
1.3 Nicotinamide Phosphoribosyltransferase by Application
1.3.1 Global Nicotinamide Phosphoribosyltransferase Market Value by Application (2024 VS 2031)
1.3.2 Parkinson's Disease
1.3.3 Acute Lung Injury
1.3.4 Breast Cancer
1.3.5 Others
1.4 Global Nicotinamide Phosphoribosyltransferase Market Size Estimates and Forecasts
1.4.1 Global Nicotinamide Phosphoribosyltransferase Revenue 2020-2031
1.4.2 Global Nicotinamide Phosphoribosyltransferase Sales 2020-2031
1.4.3 Global Nicotinamide Phosphoribosyltransferase Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Nicotinamide Phosphoribosyltransferase Market Competition by Manufacturers
2.1 Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Manufacturers (2020-2025)
2.2 Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Nicotinamide Phosphoribosyltransferase Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Nicotinamide Phosphoribosyltransferase, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Nicotinamide Phosphoribosyltransferase, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nicotinamide Phosphoribosyltransferase, Product Type & Application
2.7 Global Key Manufacturers of Nicotinamide Phosphoribosyltransferase, Date of Enter into This Industry
2.8 Global Nicotinamide Phosphoribosyltransferase Market Competitive Situation and Trends
2.8.1 Global Nicotinamide Phosphoribosyltransferase Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Nicotinamide Phosphoribosyltransferase Players Market Share by Revenue
2.8.3 Global Nicotinamide Phosphoribosyltransferase Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Nicotinamide Phosphoribosyltransferase Market Scenario by Region
3.1 Global Nicotinamide Phosphoribosyltransferase Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Nicotinamide Phosphoribosyltransferase Sales by Region: 2020-2031
3.2.1 Global Nicotinamide Phosphoribosyltransferase Sales by Region: 2020-2025
3.2.2 Global Nicotinamide Phosphoribosyltransferase Sales by Region: 2026-2031
3.3 Global Nicotinamide Phosphoribosyltransferase Revenue by Region: 2020-2031
3.3.1 Global Nicotinamide Phosphoribosyltransferase Revenue by Region: 2020-2025
3.3.2 Global Nicotinamide Phosphoribosyltransferase Revenue by Region: 2026-2031
3.4 North America Nicotinamide Phosphoribosyltransferase Market Facts & Figures by Country
3.4.1 North America Nicotinamide Phosphoribosyltransferase Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Nicotinamide Phosphoribosyltransferase Sales by Country (2020-2031)
3.4.3 North America Nicotinamide Phosphoribosyltransferase Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Nicotinamide Phosphoribosyltransferase Market Facts & Figures by Country
3.5.1 Europe Nicotinamide Phosphoribosyltransferase Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Nicotinamide Phosphoribosyltransferase Sales by Country (2020-2031)
3.5.3 Europe Nicotinamide Phosphoribosyltransferase Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nicotinamide Phosphoribosyltransferase Market Facts & Figures by Region
3.6.1 Asia Pacific Nicotinamide Phosphoribosyltransferase Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Nicotinamide Phosphoribosyltransferase Sales by Region (2020-2031)
3.6.3 Asia Pacific Nicotinamide Phosphoribosyltransferase Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Nicotinamide Phosphoribosyltransferase Market Facts & Figures by Country
3.7.1 Latin America Nicotinamide Phosphoribosyltransferase Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Nicotinamide Phosphoribosyltransferase Sales by Country (2020-2031)
3.7.3 Latin America Nicotinamide Phosphoribosyltransferase Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nicotinamide Phosphoribosyltransferase Market Facts & Figures by Country
3.8.1 Middle East and Africa Nicotinamide Phosphoribosyltransferase Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Nicotinamide Phosphoribosyltransferase Sales by Country (2020-2031)
3.8.3 Middle East and Africa Nicotinamide Phosphoribosyltransferase Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nicotinamide Phosphoribosyltransferase Sales by Type (2020-2031)
4.1.1 Global Nicotinamide Phosphoribosyltransferase Sales by Type (2020-2025)
4.1.2 Global Nicotinamide Phosphoribosyltransferase Sales by Type (2026-2031)
4.1.3 Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Type (2020-2031)
4.2 Global Nicotinamide Phosphoribosyltransferase Revenue by Type (2020-2031)
4.2.1 Global Nicotinamide Phosphoribosyltransferase Revenue by Type (2020-2025)
4.2.2 Global Nicotinamide Phosphoribosyltransferase Revenue by Type (2026-2031)
4.2.3 Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Type (2020-2031)
4.3 Global Nicotinamide Phosphoribosyltransferase Price by Type (2020-2031)
5 Segment by Application
5.1 Global Nicotinamide Phosphoribosyltransferase Sales by Application (2020-2031)
5.1.1 Global Nicotinamide Phosphoribosyltransferase Sales by Application (2020-2025)
5.1.2 Global Nicotinamide Phosphoribosyltransferase Sales by Application (2026-2031)
5.1.3 Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Application (2020-2031)
5.2 Global Nicotinamide Phosphoribosyltransferase Revenue by Application (2020-2031)
5.2.1 Global Nicotinamide Phosphoribosyltransferase Revenue by Application (2020-2025)
5.2.2 Global Nicotinamide Phosphoribosyltransferase Revenue by Application (2026-2031)
5.2.3 Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Application (2020-2031)
5.3 Global Nicotinamide Phosphoribosyltransferase Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Genentech, Inc.
6.1.1 Genentech, Inc. Company Information
6.1.2 Genentech, Inc. Description and Business Overview
6.1.3 Genentech, Inc. Nicotinamide Phosphoribosyltransferase Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Genentech, Inc. Nicotinamide Phosphoribosyltransferase Product Portfolio
6.1.5 Genentech, Inc. Recent Developments/Updates
6.2 Angelini Group
6.2.1 Angelini Group Company Information
6.2.2 Angelini Group Description and Business Overview
6.2.3 Angelini Group Nicotinamide Phosphoribosyltransferase Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Angelini Group Nicotinamide Phosphoribosyltransferase Product Portfolio
6.2.5 Angelini Group Recent Developments/Updates
6.3 Calico LLC
6.3.1 Calico LLC Company Information
6.3.2 Calico LLC Description and Business Overview
6.3.3 Calico LLC Nicotinamide Phosphoribosyltransferase Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Calico LLC Nicotinamide Phosphoribosyltransferase Product Portfolio
6.3.5 Calico LLC Recent Developments/Updates
6.4 FORMA Therapeutics, Inc.
6.4.1 FORMA Therapeutics, Inc. Company Information
6.4.2 FORMA Therapeutics, Inc. Description and Business Overview
6.4.3 FORMA Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Sales, Revenue and Gross Margin (2020-2025)
6.4.4 FORMA Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Product Portfolio
6.4.5 FORMA Therapeutics, Inc. Recent Developments/Updates
6.5 OncoTartis, Inc.
6.5.1 OncoTartis, Inc. Company Information
6.5.2 OncoTartis, Inc. Description and Business Overview
6.5.3 OncoTartis, Inc. Nicotinamide Phosphoribosyltransferase Sales, Revenue and Gross Margin (2020-2025)
6.5.4 OncoTartis, Inc. Nicotinamide Phosphoribosyltransferase Product Portfolio
6.5.5 OncoTartis, Inc. Recent Developments/Updates
6.6 Karyopharm Therapeutics, Inc.
6.6.1 Karyopharm Therapeutics, Inc. Company Information
6.6.2 Karyopharm Therapeutics, Inc. Description and Business Overview
6.6.3 Karyopharm Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Karyopharm Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Product Portfolio
6.6.5 Karyopharm Therapeutics, Inc. Recent Developments/Updates
6.7 Aurigene Discovery Technologies Limited
6.7.1 Aurigene Discovery Technologies Limited Company Information
6.7.2 Aurigene Discovery Technologies Limited Description and Business Overview
6.7.3 Aurigene Discovery Technologies Limited Nicotinamide Phosphoribosyltransferase Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Aurigene Discovery Technologies Limited Nicotinamide Phosphoribosyltransferase Product Portfolio
6.7.5 Aurigene Discovery Technologies Limited Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nicotinamide Phosphoribosyltransferase Industry Chain Analysis
7.2 Nicotinamide Phosphoribosyltransferase Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nicotinamide Phosphoribosyltransferase Production Mode & Process Analysis
7.4 Nicotinamide Phosphoribosyltransferase Sales and Marketing
7.4.1 Nicotinamide Phosphoribosyltransferase Sales Channels
7.4.2 Nicotinamide Phosphoribosyltransferase Distributors
7.5 Nicotinamide Phosphoribosyltransferase Customer Analysis
8 Nicotinamide Phosphoribosyltransferase Market Dynamics
8.1 Nicotinamide Phosphoribosyltransferase Industry Trends
8.2 Nicotinamide Phosphoribosyltransferase Market Drivers
8.3 Nicotinamide Phosphoribosyltransferase Market Challenges
8.4 Nicotinamide Phosphoribosyltransferase Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Nicotinamide Phosphoribosyltransferase Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Nicotinamide Phosphoribosyltransferase Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Nicotinamide Phosphoribosyltransferase Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Nicotinamide Phosphoribosyltransferase Sales (K MT) of Key Manufacturers (2020-2025)
 Table 5. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Nicotinamide Phosphoribosyltransferase Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Nicotinamide Phosphoribosyltransferase Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Nicotinamide Phosphoribosyltransferase Average Price (USD/MT) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Nicotinamide Phosphoribosyltransferase, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Nicotinamide Phosphoribosyltransferase, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Nicotinamide Phosphoribosyltransferase, Product Type & Application
 Table 12. Global Key Manufacturers of Nicotinamide Phosphoribosyltransferase, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Nicotinamide Phosphoribosyltransferase by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nicotinamide Phosphoribosyltransferase as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Nicotinamide Phosphoribosyltransferase Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Nicotinamide Phosphoribosyltransferase Sales by Region (2020-2025) & (K MT)
 Table 18. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Region (2020-2025)
 Table 19. Global Nicotinamide Phosphoribosyltransferase Sales by Region (2026-2031) & (K MT)
 Table 20. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Region (2026-2031)
 Table 21. Global Nicotinamide Phosphoribosyltransferase Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Region (2020-2025)
 Table 23. Global Nicotinamide Phosphoribosyltransferase Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Region (2026-2031)
 Table 25. North America Nicotinamide Phosphoribosyltransferase Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Nicotinamide Phosphoribosyltransferase Sales by Country (2020-2025) & (K MT)
 Table 27. North America Nicotinamide Phosphoribosyltransferase Sales by Country (2026-2031) & (K MT)
 Table 28. North America Nicotinamide Phosphoribosyltransferase Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Nicotinamide Phosphoribosyltransferase Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Nicotinamide Phosphoribosyltransferase Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Nicotinamide Phosphoribosyltransferase Sales by Country (2020-2025) & (K MT)
 Table 32. Europe Nicotinamide Phosphoribosyltransferase Sales by Country (2026-2031) & (K MT)
 Table 33. Europe Nicotinamide Phosphoribosyltransferase Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Nicotinamide Phosphoribosyltransferase Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Nicotinamide Phosphoribosyltransferase Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Nicotinamide Phosphoribosyltransferase Sales by Region (2020-2025) & (K MT)
 Table 37. Asia Pacific Nicotinamide Phosphoribosyltransferase Sales by Region (2026-2031) & (K MT)
 Table 38. Asia Pacific Nicotinamide Phosphoribosyltransferase Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Nicotinamide Phosphoribosyltransferase Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Nicotinamide Phosphoribosyltransferase Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Nicotinamide Phosphoribosyltransferase Sales by Country (2020-2025) & (K MT)
 Table 42. Latin America Nicotinamide Phosphoribosyltransferase Sales by Country (2026-2031) & (K MT)
 Table 43. Latin America Nicotinamide Phosphoribosyltransferase Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Nicotinamide Phosphoribosyltransferase Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Nicotinamide Phosphoribosyltransferase Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Nicotinamide Phosphoribosyltransferase Sales by Country (2020-2025) & (K MT)
 Table 47. Middle East and Africa Nicotinamide Phosphoribosyltransferase Sales by Country (2026-2031) & (K MT)
 Table 48. Middle East and Africa Nicotinamide Phosphoribosyltransferase Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Nicotinamide Phosphoribosyltransferase Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Nicotinamide Phosphoribosyltransferase Sales (K MT) by Type (2020-2025)
 Table 51. Global Nicotinamide Phosphoribosyltransferase Sales (K MT) by Type (2026-2031)
 Table 52. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Type (2020-2025)
 Table 53. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Type (2026-2031)
 Table 54. Global Nicotinamide Phosphoribosyltransferase Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Nicotinamide Phosphoribosyltransferase Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Type (2020-2025)
 Table 57. Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Type (2026-2031)
 Table 58. Global Nicotinamide Phosphoribosyltransferase Price (USD/MT) by Type (2020-2025)
 Table 59. Global Nicotinamide Phosphoribosyltransferase Price (USD/MT) by Type (2026-2031)
 Table 60. Global Nicotinamide Phosphoribosyltransferase Sales (K MT) by Application (2020-2025)
 Table 61. Global Nicotinamide Phosphoribosyltransferase Sales (K MT) by Application (2026-2031)
 Table 62. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Application (2020-2025)
 Table 63. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Application (2026-2031)
 Table 64. Global Nicotinamide Phosphoribosyltransferase Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Nicotinamide Phosphoribosyltransferase Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Application (2020-2025)
 Table 67. Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Application (2026-2031)
 Table 68. Global Nicotinamide Phosphoribosyltransferase Price (USD/MT) by Application (2020-2025)
 Table 69. Global Nicotinamide Phosphoribosyltransferase Price (USD/MT) by Application (2026-2031)
 Table 70. Genentech, Inc. Company Information
 Table 71. Genentech, Inc. Description and Business Overview
 Table 72. Genentech, Inc. Nicotinamide Phosphoribosyltransferase Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 73. Genentech, Inc. Nicotinamide Phosphoribosyltransferase Product
 Table 74. Genentech, Inc. Recent Developments/Updates
 Table 75. Angelini Group Company Information
 Table 76. Angelini Group Description and Business Overview
 Table 77. Angelini Group Nicotinamide Phosphoribosyltransferase Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 78. Angelini Group Nicotinamide Phosphoribosyltransferase Product
 Table 79. Angelini Group Recent Developments/Updates
 Table 80. Calico LLC Company Information
 Table 81. Calico LLC Description and Business Overview
 Table 82. Calico LLC Nicotinamide Phosphoribosyltransferase Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 83. Calico LLC Nicotinamide Phosphoribosyltransferase Product
 Table 84. Calico LLC Recent Developments/Updates
 Table 85. FORMA Therapeutics, Inc. Company Information
 Table 86. FORMA Therapeutics, Inc. Description and Business Overview
 Table 87. FORMA Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 88. FORMA Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Product
 Table 89. FORMA Therapeutics, Inc. Recent Developments/Updates
 Table 90. OncoTartis, Inc. Company Information
 Table 91. OncoTartis, Inc. Description and Business Overview
 Table 92. OncoTartis, Inc. Nicotinamide Phosphoribosyltransferase Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 93. OncoTartis, Inc. Nicotinamide Phosphoribosyltransferase Product
 Table 94. OncoTartis, Inc. Recent Developments/Updates
 Table 95. Karyopharm Therapeutics, Inc. Company Information
 Table 96. Karyopharm Therapeutics, Inc. Description and Business Overview
 Table 97. Karyopharm Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 98. Karyopharm Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Product
 Table 99. Karyopharm Therapeutics, Inc. Recent Developments/Updates
 Table 100. Aurigene Discovery Technologies Limited Company Information
 Table 101. Aurigene Discovery Technologies Limited Description and Business Overview
 Table 102. Aurigene Discovery Technologies Limited Nicotinamide Phosphoribosyltransferase Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 103. Aurigene Discovery Technologies Limited Nicotinamide Phosphoribosyltransferase Product
 Table 104. Aurigene Discovery Technologies Limited Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Nicotinamide Phosphoribosyltransferase Distributors List
 Table 108. Nicotinamide Phosphoribosyltransferase Customers List
 Table 109. Nicotinamide Phosphoribosyltransferase Market Trends
 Table 110. Nicotinamide Phosphoribosyltransferase Market Drivers
 Table 111. Nicotinamide Phosphoribosyltransferase Market Challenges
 Table 112. Nicotinamide Phosphoribosyltransferase Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Nicotinamide Phosphoribosyltransferase
 Figure 2. Global Nicotinamide Phosphoribosyltransferase Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Nicotinamide Phosphoribosyltransferase Market Share by Type: 2024 & 2031
 Figure 4. Hormone Product Picture
 Figure 5. Lipids Product Picture
 Figure 6. Small Molecule Compounds Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Nicotinamide Phosphoribosyltransferase Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Nicotinamide Phosphoribosyltransferase Market Share by Application: 2024 & 2031
 Figure 10. Parkinson's Disease
 Figure 11. Acute Lung Injury
 Figure 12. Breast Cancer
 Figure 13. Others
 Figure 14. Global Nicotinamide Phosphoribosyltransferase Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Nicotinamide Phosphoribosyltransferase Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Nicotinamide Phosphoribosyltransferase Sales (2020-2031) & (K MT)
 Figure 17. Global Nicotinamide Phosphoribosyltransferase Average Price (USD/MT) & (2020-2031)
 Figure 18. Nicotinamide Phosphoribosyltransferase Report Years Considered
 Figure 19. Nicotinamide Phosphoribosyltransferase Sales Share by Manufacturers in 2024
 Figure 20. Global Nicotinamide Phosphoribosyltransferase Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Nicotinamide Phosphoribosyltransferase Players: Market Share by Revenue in Nicotinamide Phosphoribosyltransferase in 2024
 Figure 22. Nicotinamide Phosphoribosyltransferase Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Nicotinamide Phosphoribosyltransferase Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Nicotinamide Phosphoribosyltransferase Sales Market Share by Country (2020-2031)
 Figure 25. North America Nicotinamide Phosphoribosyltransferase Revenue Market Share by Country (2020-2031)
 Figure 26. U.S. Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Nicotinamide Phosphoribosyltransferase Sales Market Share by Country (2020-2031)
 Figure 29. Europe Nicotinamide Phosphoribosyltransferase Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Nicotinamide Phosphoribosyltransferase Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Nicotinamide Phosphoribosyltransferase Revenue Market Share by Region (2020-2031)
 Figure 37. China Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Taiwan Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Philippines Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Nicotinamide Phosphoribosyltransferase Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Nicotinamide Phosphoribosyltransferase Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Nicotinamide Phosphoribosyltransferase Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Nicotinamide Phosphoribosyltransferase Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. UAE Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Nicotinamide Phosphoribosyltransferase by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Nicotinamide Phosphoribosyltransferase by Type (2020-2031)
 Figure 59. Global Nicotinamide Phosphoribosyltransferase Price (USD/MT) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Nicotinamide Phosphoribosyltransferase by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Nicotinamide Phosphoribosyltransferase by Application (2020-2031)
 Figure 62. Global Nicotinamide Phosphoribosyltransferase Price (USD/MT) by Application (2020-2031)
 Figure 63. Nicotinamide Phosphoribosyltransferase Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

RELATED REPORTS

Global Taurine and Derivatives Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26D19461
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global OTC Hydrotalcite Chewable Tablets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-18S16538
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Women's Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14W1499
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Yohimbine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35Y1251
Thu Sep 11 00:00:00 UTC 2025

Add to Cart